Inventor · disambiguated record
Yifeng Xiong
Also filed as: XIONG YIFENG
34 granted patents·26 pending applications·386 citations·filing 2004–2025
97Inventor score
Files withARENA PHARM INC30JONES ROBERT M7CONTINEUM THERAPEUTICS INC5PIPELINE THERAPEUTICS INC4XIONG YIFENG4
Top patents by PatentIndex Score
60 records- 0196US11771695B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2021·Granted Oct 3, 2023·4 cites·11 claims
- 0296US7884101B23-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2006·Granted Feb 8, 2011·42 cites·2 claims
- 0395US9732039B2Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2015·Granted Aug 15, 2017·17 cites·13 claims
- 0495US9567327B2Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoXIONG YIFENG·Filed 2008·Granted Feb 14, 2017·57 cites·38 claims
- 0594US8778950B2Cannabinoid receptor modulatorsJONES ROBERT M·Filed 2010·Granted Jul 15, 2014·21 cites·6 claims
- 0694US7838525B2Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2006·Granted Nov 23, 2010·39 cites·69 claims
- 0793US7132426B2Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2004·Granted Nov 7, 2006·56 cites·57 claims
- 0892US11752149B2Muscarinic acetylcholine M1 receptor antagonistsPIPELINE THERAPEUTICS INC·Filed 2020·Granted Sep 12, 2023·3 cites·2 claims
- 0992US11214548B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2019·Granted Jan 4, 2022·3 cites·8 claims
- 1092US10632134B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2017·Granted Apr 28, 2020·5 cites·16 claims
- 1191US9867822B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2016·Granted Jan 16, 2018·7 cites·18 claims
- 1291US9492447B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2015·Granted Nov 15, 2016·9 cites·20 claims
- 1391US9434692B2Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoXIONG YIFENG·Filed 2007·Granted Sep 6, 2016·18 cites·15 claims
- 1491US7470699B2Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2004·Granted Dec 30, 2008·41 cites·57 claims
- 1590US8785441B23-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoTEEGARDEN BRADLEY·Filed 2012·Granted Jul 22, 2014·11 cites·16 claims
- 1688US9597340B2Cannabinoid receptor modulatorsTHATTE JAYANT·Filed 2012·Granted Mar 21, 2017·9 cites·17 claims
- 1788US7625906B2Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2006·Granted Dec 1, 2009·11 cites·50 claims
- 1886US8410119B2Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoJONES ROBERT M·Filed 2009·Granted Apr 2, 2013·8 cites·54 claims
- 1985US11512090B2Muscarinic acetylcholine M1 receptor antagonistsPIPELINE THERAPEUTICS INC·Filed 2019·Granted Nov 29, 2022·4 cites·19 claims
- 2085US10058549B2Imidazo[1,2-α]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2017·Granted Aug 28, 2018·4 cites·12 claims
- 2182US11780827B2Substituted 3-phenoxyazetidin-1-yl-pyrazinesBOEHRINGER INGELHEIM INT·Filed 2021·Granted Oct 10, 2023·1 cites·11 claims
- 2281US9944606B2Cannabinoid receptor modulatorsJONES ROBERT M·Filed 2012·Granted Apr 17, 2018·3 cites·30 claims
- 2380US12054487B2Muscarinic acetylcholine M1 receptor antagonistsCONTINEUM THERAPEUTICS INC·Filed 2019·Granted Aug 6, 2024·2 cites·18 claims
- 2477US2022306586A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2021·Application pending·0 cites
- 2575US9676758B21-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related theretoARENA PHARM INC·Filed 2016·Granted Jun 13, 2017·3 cites·41 claims
- 2674US12390462B2Muscarinic acetylcholine M1 receptor antagonistsCONTINEUM THERAPEUTICS INC·Filed 2023·Granted Aug 19, 2025·0 cites·6 claims
- 2774US11746091B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2020·Granted Sep 5, 2023·0 cites·12 claims
- 2874US2021380537A1Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2021·Application pending·0 cites
- 2973US8293751B21,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemiaJONES ROBERT M·Filed 2004·Granted Oct 23, 2012·8 cites·85 claims
- 3072US2025026758A1Muscarinic acetylcholine m1 receptor antagonistsCONTINEUM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3168US10781180B23-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2018·Granted Sep 22, 2020·0 cites·39 claims
- 3268US2021128552A1Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2020·Application pending·0 cites
- 3367US2020069681A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2019·Application pending·0 cites
- 3466US2020048205A1Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2019·Application pending·0 cites
- 3564US12109219B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2020·Granted Oct 8, 2024·0 cites·20 claims
- 3664US10351531B2Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2017·Granted Jul 16, 2019·0 cites·22 claims
- 3764US2018354907A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2018·Application pending·0 cites
- 3863US2018280386A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2017·Application pending·0 cites
- 3961US2025213735A1Neuropeptide y1 receptor (npy1r) targeted therapeutics and uses thereofRADIONETICS ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 4060US12115157B23-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2022·Granted Oct 15, 2024·0 cites·15 claims
- 4160US2007072844A1Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARM INC·Filed 2006·Application pending·0 cites
- 4259US2013217700A1Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoXIONG YIFENG·Filed 2012·Application pending·0 cites
- 4359US2007082874A1Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related theretoARENA PHARMACEUTICLAS INC·Filed 2006·Application pending·0 cites
- 4459US2007244086A13-Phenyl-Pyrazole Derivatives as Modulators of the 5-Ht2A Serotonin Receptor Useful for the Treatment of Disorders Related TheretoARENA PHARM INC·Filed 2005·Application pending·0 cites
- 4559US2019142826A1Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoXIONG YIFENG·Filed 2018·Application pending·0 cites
- 4658US2016304463A13-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2016·Application pending·0 cites
- 4758US2024226343A1Neuropeptide y1 receptor (npy1r) targeted therapeutics and uses thereofRADIONETICS ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 4858US2025034110A1Lpar1 antagonists and uses thereofPIPELINE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4957US2024217981A1Crystalline compound of muscarinic acetylcholine m1 receptor antagonistsPIPELINE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 5057US2025179045A1Lpar1 antagonists and uses thereofCONTINEUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yifeng Xiong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →